Sign in

NCT07374367Not yet recruiting

Isthmin-1 as a Biomarker of Disease Activity in Rheumatoid Arthritis: Correlation With Musculoskeletal Ultrasound Findings

Serum Isthmin-1 Level as a Biomarker of Disease Activity in Rheumatoid Arthritis: Correlation With Musculoskeletal Ultrasound Findings

Source: ClinicalTrials.gov · Last updated 28 Jan 2026

Brief summary (registry, in English)

The goal of this case control study is to detect serum isthmin-1 level in RA patient compered to healthy control . The main questions it aims to answer are: what is the serum isthmin-1 level in RA patient? what is the correlation between serum isthmin-1 and RA disease activity? what is the correlation between serum isthmin-1 level and MSUS finding in RA patients?

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
66 (estimated)
First submitted
16 Jan 2026
Start date
1 May 2026
Primary completion date
1 Sept 2027
Lead sponsor
Amera Imam Abdel - Ghany Ahmed
NCT number
NCT07374367

What you commit to

  • Study type: Observational
  • Planned participants: 66
  • From 1 May 2026 to the primary completion date, 1 Sept 2027
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients with other autoimmune diseases.
  • Participants with active infections, malignancies or diabetes.
  • Recent hand surgery, trauma, deformity and neurological conditions affecting hand function

Age

  • Patients less than 18 years old.

Who the study is looking for

  • -Adult patients (≥18 years old) clinically diagnosed with rheumatoid arthritis according to the 2010 ACR/EULAR classification criteria.

Age in the registry: 18 years to 65 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.